Novo Nordisk A/S Series B

Sanofi to cap price of Lantus insulin at $35

4:24 p.m. March 16, 2023

- Jaimy Lee

Biden stresses inflation report shows slowest annual rise since September 2021

10:26 a.m. March 14, 2023

- Victor Reklaitis

Novo Nordisk to lower prices of some insulins, following similar move by Lilly

8:45 a.m. March 14, 2023

- Jaimy Lee

Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval

10:43 a.m. Feb. 15, 2023

- Jaimy Lee

Lilly’s Type 2 diabetes drug Mounjaro didn’t sell enough to impress, analysts say

8:10 a.m. Feb. 3, 2023

- Jaimy Lee

Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts

3:25 a.m. Feb. 1, 2023

- Dominic Chopping

California is latest state to sue drug companies over high insulin prices

6:22 p.m. Jan. 12, 2023

- Associated Press

Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity

8:22 a.m. Nov. 2, 2022

- Jaimy Lee

Novo Nordisk lifts guidance as earnings beat expectations

3:07 a.m. Nov. 2, 2022

- Dominic Chopping

‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?

3:44 p.m. Oct. 6, 2022

- Jaimy Lee

AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say

7:48 a.m. Sept. 14, 2022

- Anviksha Patel

The bear market in stocks has a long way to go, this money manager warns. Here are the 2 strategic moves he’s making.

9:33 a.m. Sept. 1, 2022

- Barbara Kollmeyer

Forma Therapeutics to be acquired by Novo Nordisk in a cash deal valued at $1.1 billion

8:18 a.m. Sept. 1, 2022

- Tomi Kilgore

Novo Nordisk expects deal to close in Q4

8:05 a.m. Sept. 1, 2022

- Ciara Linnane

Novo Nordisk to acquire Forma Therapeutics in cash deal with equity value of $1.1 bln

8:04 a.m. Sept. 1, 2022

- Ciara Linnane

Novo Nordisk upgraded to overweight from neutral at J.P. Morgan

6:44 a.m. June 7, 2022

- Tomi Kilgore

Lilly’s experimental obesity drug may be a ‘multibillion-dollar opportunity’

8:20 a.m. May 2, 2022

- Jaimy Lee

This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst

10:14 a.m. March 22, 2022

- Barbara Kollmeyer

European stocks advance after partial Russian troop withdrawal

9:55 a.m. Feb. 15, 2022

- Steve Goldstein

GlaxoSmithKline shares soar after Unilever bids for its consumer healthcare unit

7:56 a.m. Jan. 17, 2022

- Barbara Kollmeyer

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition